These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 21465808)

  • 1. [Bioluminescence imaging evaluation of the inhibitory effect of lidamycin on lung metastasis of human fibrosarcoma in athymic mice].
    Zhang SH; Zhong GS; He HW; Cheng X; Zhen YS
    Yao Xue Xue Bao; 2011 Jan; 46(1):45-9. PubMed ID: 21465808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Lidamycin inhibits the proliferation of HERG K+ channel highly expressing cancer cells and shows synergy with anticancer drugs].
    Shang BY; Shang Y; Zhen YS; Chen SZ
    Yao Xue Xue Bao; 2011 Nov; 46(11):1321-5. PubMed ID: 22260022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lidamycin up-regulates the expression of thymidine phosphorylase and enhances the effects of capecitabine on the growth and pulmonary metastases of murine breast carcinoma.
    Zhang SH; Zhang H; He HW; Li L; Li XQ; Zhang YP; Shao RG
    Cancer Chemother Pharmacol; 2013 Oct; 72(4):777-88. PubMed ID: 23975242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lidamycin induces apoptosis of human gastric carcinoma BGC823 cells and inhibits xenograft growth in nude mice].
    Zhang SH; Chen J; Jiang M; Zhen YS
    Yao Xue Xue Bao; 2008 Jun; 43(6):601-4. PubMed ID: 18822962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Synergistic effect and its possible mechanisms of lidamycin in combination with TRAIL in NSCLC].
    Yang J; Chen SZ
    Yao Xue Xue Bao; 2010 Oct; 45(10):1247-53. PubMed ID: 21348302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor activities of various immunoconjugates composed of lidamycin and anti-type IV collagenase monoclonal antibody].
    Feng Y; Zhen YS; Dai Y; Shang BY; Zhang M; He HW; Li BW; Shao RG
    Yao Xue Xue Bao; 2007 Jul; 42(7):704-9. PubMed ID: 17882952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of the antitumor activities of immunoconjugates composed of lidamycin and monoclonal antibody fab' fragment with different linkers].
    Feng Y; Shao RG; Dai Y; Li BW; He HW; Ren KH
    Yao Xue Xue Bao; 2010 May; 45(5):571-5. PubMed ID: 20931757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chloroquine potentiates the anti-cancer effect of lidamycin on non-small cell lung cancer cells in vitro.
    Liu F; Shang Y; Chen SZ
    Acta Pharmacol Sin; 2014 May; 35(5):645-52. PubMed ID: 24727941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidamycin inhibits the cancer cell PKC activity induced by basic fibroblast growth factor.
    Zhen HY; Huang YH; Zhen YS
    Yao Xue Xue Bao; 2005 Dec; 40(12):1110-5. PubMed ID: 16496675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antibody to plasminogen activator inhibitor-1 suppresses pulmonary metastases of human fibrosarcoma in athymic mice.
    Tsuchiya H; Katsuo S; Matsuda E; Sunayama C; Tomita K; Ueda Y; Binder BR
    Gen Diagn Pathol; 1995 May; 141(1):41-8. PubMed ID: 8542506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inhibitory effects of the immunoconjugate composed of anti-type IV collagenase antibody Fab' fragment and lidamycin on tumor invasion and metastasis].
    Feng Y; He HW; Li BW; Zhang ZX; Chen X; Li XF
    Yao Xue Xue Bao; 2011 Dec; 46(12):1462-5. PubMed ID: 22375419
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen activator inhibitor-1 accelerates lung metastasis formation of human fibrosarcoma cells.
    Tsuchiya H; Sunayama C; Okada G; Matsuda E; Tomita K; Binder BR
    Anticancer Res; 1997; 17(1A):313-6. PubMed ID: 9066670
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of the nuclear factor-kappaB by lidamycin in association with inducing apoptosis in human pancreatic cancer cells and inhibiting xenograft growth.
    Chen J; Ouyang ZG; Zhang SH; Zhen YS
    Oncol Rep; 2007 Jun; 17(6):1445-51. PubMed ID: 17487403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemokine receptor CXCR4 gene silencing with shRNA inhibits breast cancer metastasis to the lung in nude mice].
    Zhang MX; Han N; Yu SY; Leng Y
    Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):325-9. PubMed ID: 18953828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antitumor effects of the immunoconjugate composed of lidamycin and monoclonal antibody 3G11].
    Wang FQ; Shang BY; Zhen YS
    Yao Xue Xue Bao; 2003 Jul; 38(7):515-9. PubMed ID: 14515796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inhibitory effect of lidamycin on growth of colon carcinoma 26 and hepatic metastasis in mice].
    Liu XJ; Dai Y; Shang Y; Li Y; Zhen YS
    Ai Zheng; 2005 Jun; 24(6):641-5. PubMed ID: 15946470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft.
    Bigioni M; Benzo A; Irrissuto C; Lopez G; Curatella B; Maggi CA; Manzini S; Crea A; Caroli S; Cubadda F; Binaschi M
    Cancer Chemother Pharmacol; 2008 Sep; 62(4):621-9. PubMed ID: 18038274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tandem scFv-based fusion protein and its enediyne-energized analogue show intensified therapeutic efficacy against lung carcinoma xenograft in athymic mice.
    Zhong G; Zhang S; Li Y; Liu X; Gao R; Miao Q; Zhen Y
    Cancer Lett; 2010 Sep; 295(1):124-33. PubMed ID: 20303650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An experimental study on the therapeutic effect of consecutive low-dose cisplatin with caffeine in sarcoma-bearing mice.
    Takeda A; Tsuchiya H; Tajino T; Kikuchi S
    Anticancer Res; 2005; 25(4):2777-84. PubMed ID: 16080526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ; Tian H; Joseph IB; Menon K; Frost D
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.